Hu Luo

Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines

Xiuping Yan, Hu Luo, Xiangdong Zhou et al. · Oncology Reports · 2013 · 94 citations · Full text

Medicine, Cell Biology, Oncology +12

Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells

Chunlan Tang, Hu Luo, Dan Luo et al. · Oncology Reports · 2017 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +17

Pneumonia-Plus: a deep learning model for the classification of bacterial, fungal, and viral pneumonia based on CT tomography

Fang Wang, Xiaoming Li, Ru Wen et al. · European Radiology · 2023 · 20 citations

Medicine, Infectious Diseases, Radiology +16

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798

Xuemei Yang, Chunlan Tang, Hu Luo et al. · Oncotarget · 2017 · 16 citations · Full text

Medicine, Molecular Biology, Oncology +16

Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial)

Hu Luo, Liang Gong, Bingjing Zhu et al. · Trials · 2013 · 14 citations · Full text

Medicine, Oncology, Pharmacology +15